Suchergebnisse - "Umberto Restelli"

PubPharm (7)

1

Assessment of the Costs Related to West Nile Virus Monitoring in Lombardy Region (Italy) between 2014 and 2018

in: International Journal of Environmental Research and Public Health | 2022

von Francesco Defilippo | Michele Dottori | Davide Lelli | +12

2

What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres

in: Antimicrobial Resistance and Infection Control | 2022

von Agnese Comelli | Camilla Genovese | Andrea Lombardi | +24

3

The Management of Psoriatic Arthritis in Italy: Organizational Impact Analysis of Optimized Pathways

in: Farmeconomia: Health Economics and Therapeutic Pathways | 2019

von Umberto Restelli | Carlo Selmi | Valeria Pacelli | +2

4

Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients

in: Farmeconomia: Health Economics and Therapeutic Pathways | 2016

von Umberto Restelli | Alfredo Alberti | Adriano Lazzarin | +3

5

Organizational Impact of the Introduction of a New Portable Syringe Pump for Iloprost Therapy in Italian Hospital Settings

enthalten in: Current drug therapy | 2015

von Umberto Restelli | Paola Faggioli | Francesca Scolari | +5

6

Correction: Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World.

in: PLoS ONE | 2014

von Emanuela Foglia | Paolo Bonfanti | Giuliano Rizzardini | +6

7

Cost-utility analysis of lopinavir/ritonavir versus atazanavir + ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial to real world.

in: PLoS ONE | 2013

von Emanuela Foglia | Paolo Bonfanti | Giuliano Rizzardini | +6

1
[1]